VIA Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
Interested parties may access a live audio webcast of the presentationfrom the investor section of the VIA website, www.viapharmaceuticals.com. Areplay of the presentation will be archived on the site for at least one weekfollowing the presentation.
About VIA Pharmaceuticals, Inc.
VIA Pharmaceuticals, Inc. is a biotechnology company focused on thedevelopment of compounds for the treatment of cardiovascular disease. VIA isbuilding a pipeline of small-molecule drugs that target a significant unmetmedical need: reducing inflammation in the blood vessel wall, which is anunderlying cause of atherosclerosis and its complications, including heartattack and stroke. The company's lead drug candidate, VIA-2291, is inmultiple Phase 2 clinical studies in patients with cardiovascular disease. Formore information, visit: www.viapharmaceuticals.com.
SOURCE VIA Pharmaceuticals
You May Also Like